HN might inhibit neurodegeneration caused by polyQ diseases, such as dentatorubral-pallidoluysian atrophy (DRPLA), through the suppression of ASK1 and preventing the formation of polyQ aggregates (Kariya et al., 2005). Here, MAP3K5 is linked to Dentatorubral pallidoluysian atrophy.